{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:01:30Z","timestamp":1777554090524,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:p>The skin serves as the foremost barrier between the internal body and the external world, providing crucial protection against pathogens and chemical, mechanical, and ultraviolet damages. The skin is a central player in the intricate network of immune, neurologic, and endocrine systems. The endocannabinoid system (ECS) includes an extensive network of bioactive lipid mediators and their receptors, functions to modulate appetite, pain, mood, and memory, and has recently been implicated in skin homeostasis. Disruption of ECS homeostasis is implicated in the pathogenesis of several prevalent skin conditions. In this review, we highlight the role of endocannabinoids in maintaining skin health and homeostasis and discuss evidence on the role of ECS in several eczematous dermatoses including atopic dermatitis, asteatotic eczema, irritant contact dermatitis, allergic contact dermatitis, and chronic pruritus. The compilation of evidence may spark directions for future investigations on how the ECS may be a therapeutic target for dermatologic conditions.<\/jats:p>","DOI":"10.1097\/der.0000000000000257","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T14:38:55Z","timestamp":1484663935000},"page":"22-32","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["The Endocannabinoid System and Its Role in Eczematous Dermatoses"],"prefix":"10.1177","volume":"28","author":[{"given":"Alexandra R.","family":"Trusler","sequence":"first","affiliation":[{"name":"From the *Drexel University College of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley K.","family":"Clark","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja K.","family":"Sivamani","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, Davis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[{"name":"Dermatology Division, Department of Medicine, University of Arizona, Tucson."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2005"},{"issue":"2","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0923-1811(02)00103-2","article-title":"Neuromediators\u2014a crucial component of the skin immune system","volume":"30","author":"Luger TA","year":"2002","unstructured":"Luger TA. Neuromediators\u2014a crucial component of the skin immune system. J Dermatol Sci, 2002; 30(2):87\u201393.","journal-title":"J Dermatol Sci"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21260"},{"key":"e_1_3_1_5_2","first-page":"37","article-title":"Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS","volume":"8","author":"Badowski ME","year":"2016","unstructured":"Badowski ME, , Perez SE. Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS. HIV AIDS (Auckl), 2016; 8:37\u201345.","journal-title":"HIV AIDS (Auckl)"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2016.0094"},{"issue":"12","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1080\/14737175.2016.1207531","article-title":"Recent strategies for drug development in fibromyalgia syndrome","volume":"16","author":"Blumenthal DE","year":"2016","unstructured":"Blumenthal DE, , Malemud CJ. Recent strategies for drug development in fibromyalgia syndrome. Expert Rev Neurother, 2016; 16(12):1407\u20131411.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"e_1_3_1_8_2","first-page":"20","article-title":"Efficacy of rimonabant in obese patients with binge eating disorder","volume":"121","author":"Pataky Z","year":"2013","unstructured":"Pataky Z, , Gasteyger C, , Ziegler O, et al. Efficacy of rimonabant in obese patients with binge eating disorder. Exp Clin Endocrinol Diabetes, 2013; 121(1):20\u201326.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.05.004"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2012.10.003"},{"issue":"3","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","article-title":"Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin","volume":"38","author":"Stander S","year":"2005","unstructured":"Stander S, , Schmelz M, , Metze D, et al. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci, 2005; 38(3):177\u2013188.","journal-title":"J Dermatol Sci"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142265"},{"issue":"13","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1096\/fj.06-7689com","article-title":"Inhibition of human hair follicle growth by endo- and exocannabinoids","volume":"21","author":"Telek A","year":"2007","unstructured":"Telek A, , Biro T, , Bodo E, et al. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J, 2007; 21(13):3534\u20133541.","journal-title":"FASEB J"},{"issue":"10","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-104877","article-title":"Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling","volume":"22","author":"Dobrosi N","year":"2008","unstructured":"Dobrosi N, , Toth BI, , Nagy G, et al. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J, 2008; 22(10):3685\u20133695.","journal-title":"FASEB J"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705896"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5464.306"},{"issue":"1","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/jpet.102.040675","article-title":"Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes","volume":"304","author":"Southall MD","year":"2003","unstructured":"Southall MD, , Li T, , Gharibova LS, et al. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther, 2003; 304(1):217\u2013222.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3247"},{"issue":"3","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.bjp.0704732","article-title":"Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism","volume":"136","author":"Smart D","year":"2002","unstructured":"Smart D, , Jonsson KO, , Vandevoorde S, et al \u2018Entourage\u2019 effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol, 2002; 136(3):452\u2013458.","journal-title":"Br J Pharmacol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)02934-9"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/384083a0"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152334899"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2010.02.003"},{"issue":"6","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","article-title":"N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities","volume":"92","author":"Petrosino S","year":"2010","unstructured":"Petrosino S, , Iuvone T, , Di Marzo V. N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie, 2010; 92(6):724\u2013727.","journal-title":"Biochimie"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606646200"},{"issue":"49","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"17541","DOI":"10.1073\/pnas.0508644102","article-title":"Toward an anandamide transporter","volume":"102","author":"Mechoulam R","year":"2005","unstructured":"Mechoulam R, , Deutsch DG. Toward an anandamide transporter. Proc Natl Acad Sci U S A, 2005; 102(49):17541\u201317542.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein B","year":"2008","unstructured":"Eberlein B, , Eicke C, , Reinhardt HW, et al. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol, 2008; 22(1):73\u201382.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S65448"},{"issue":"4","key":"e_1_3_1_29_2","first-page":"208","article-title":"Use of a palmitoylethanolamide containing nonsteroidal cream for treating atopic dermatitis: impact on the duration of response and time between flares","volume":"20","author":"Del Rosso JQ","year":"2007","unstructured":"Del Rosso JQ. Use of a palmitoylethanolamide containing nonsteroidal cream for treating atopic dermatitis: impact on the duration of response and time between flares. Cosmet Dermatol, 2007; 20(4):208\u2013211.","journal-title":"Cosmet Dermatol"},{"issue":"2","key":"e_1_3_1_30_2","first-page":"80","article-title":"Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study","volume":"15","author":"Pulvirenti N","year":"2007","unstructured":"Pulvirenti N, , Nasca MR, , Micali G. Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study. Acta Dermatovenerol Croat, 2007; 15(2):80\u201383.","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-003-1162-z"},{"issue":"9","key":"e_1_3_1_32_2","first-page":"801","article-title":"Topical cannabinoid agonists","volume":"57","author":"Stander S","year":"2006","unstructured":"Stander S, , Reinhardt HW, , Luger TA. Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus [in German]. Hautarzt, 2006; 57(9):801\u2013807.","journal-title":"An effective new possibility for treating chronic pruritus [in German]. Hautarzt"},{"issue":"2","key":"e_1_3_1_33_2","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study","volume":"13","author":"Szepietowski JC","year":"2005","unstructured":"Szepietowski JC, , Szepietowski T, , Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. Acta Dermatovenerol Croat, 2005; 13(2):97\u2013103.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino S","year":"2010","unstructured":"Petrosino S, , Cristino L, , Karsak M, et al. Protective role of palmitoylethanolamide in contact allergic dermatitis. Allergy, 2010; 65(6):698\u2013711.","journal-title":"Allergy"},{"issue":"12","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.4049\/jimmunol.177.12.8796","article-title":"Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice","volume":"177","author":"Oka S","year":"2006","unstructured":"Oka S, , Wakui J, , Ikeda S, et al. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J Immunol, 2006; 177(12):8796\u20138805.","journal-title":"J Immunol"},{"issue":"14","key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.12968\/bjon.2009.18.14.43356","article-title":"Skin barrier breakdown: a renaissance in emollient therapy","volume":"18","author":"Cork MJ","year":"2009","unstructured":"Cork MJ, , Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs, 2009; 18(14): 872, 874, 876\u2013877.","journal-title":"Br J Nurs"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.08.015"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130490"},{"issue":"4","key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11882-008-0048-0","article-title":"Skin barrier function","volume":"8","author":"Elias PM","year":"2008","unstructured":"Elias PM. Skin barrier function. Curr Allergy Asthma Rep, 2008; 8(4):299\u2013305.","journal-title":"Curr Allergy Asthma Rep"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.006353"},{"issue":"5","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.12788\/j.sder.2016.041","article-title":"Update on epidemiology, diagnosis, and disease course of atopic dermatitis","volume":"35","author":"Simpson ELMM","year":"2016","unstructured":"Simpson ELMM, , Irvine ADM, , Eichenfield LFM, et al. Update on epidemiology, diagnosis, and disease course of atopic dermatitis. Semin Cutan Med Surg, 2016; 35(5 Suppl):S84\u2013S88.","journal-title":"Semin Cutan Med Surg"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000370220"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.02.045"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/3-540-31301-X_10","volume-title":"Contact Dermatitis","author":"Coenraads PJ.","year":"2006","unstructured":"Coenraads PJ. Epidemiology. In: Frosh PJ, , Menne T, , Lepoittevin JP, eds. Contact Dermatitis. 4th ed. Germany: Springer-Verlag; 2006:135\u2013140.","edition":"4"},{"issue":"3","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0733-8635(18)30072-X","article-title":"The epidemiology of occupational contact dermatitis","volume":"13","author":"Lushniak BD","year":"1995","unstructured":"Lushniak BD. The epidemiology of occupational contact dermatitis. Dermatol Clin, 1995; 13(3):671\u2013680.","journal-title":"Dermatol Clin"},{"issue":"5","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"e97772","DOI":"10.1371\/journal.pone.0097772","article-title":"Proteomic analysis of the human skin proteome after in vivo treatment with sodium dodecyl sulphate","volume":"9","author":"Parkinson E","year":"2014","unstructured":"Parkinson E, , Skipp P, , Aleksic M, et al. Proteomic analysis of the human skin proteome after in vivo treatment with sodium dodecyl sulphate. PLoS One, 2014; 9(5): e97772.","journal-title":"PLoS One"},{"issue":"8","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1600-0625.2009.00923.x","article-title":"Cannabinoid system in the skin - a possible target for future therapies in dermatology","volume":"18","author":"Kupczyk P","year":"2009","unstructured":"Kupczyk P, , Reich A, , Szepietowski JC. Cannabinoid system in the skin - a possible target for future therapies in dermatology. Exp Dermatol, 2009; 18(8):669\u2013679.","journal-title":"Exp Dermatol"},{"issue":"8","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci L","year":"1995","unstructured":"Facci L, , Dal Toso R, , Romanello S, et al. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A, 1995; 92(8):3376\u20133380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01007-8"},{"issue":"8","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"Pl125","DOI":"10.1016\/S0024-3205(98)00324-5","article-title":"Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice","volume":"63","author":"Berdyshev E","year":"1998","unstructured":"Berdyshev E, , Boichot E, , Corbel M, et al. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci, 1998; 63(8):Pl125\u2013129.","journal-title":"Life Sci"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00041-4"},{"issue":"2","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/1574884711666160511150126","article-title":"Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review","volume":"11","author":"Derakhshan N","year":"2016","unstructured":"Derakhshan N, , Kazemi M. Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review. Curr Clin Pharmacol, 2016; 11(2):146\u2013147.","journal-title":"Curr Clin Pharmacol"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tvjl.2015.10.060","article-title":"Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis","volume":"207","author":"Petrosino S","year":"2016","unstructured":"Petrosino S, , Puigdemont A, , Della Valle MF, et al. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. Vet J, 2016; 207:85\u201391.","journal-title":"Vet J"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64628"},{"issue":"3","key":"e_1_3_1_56_2","first-page":"AB80","article-title":"The efficacy and safety of Mimyx cream in reducing the risk of relapse in Atopic Dermatitis","volume":"54","author":"Laumann A","year":"2006","unstructured":"Laumann A, , Lai S, , Lucky A, et al. The efficacy and safety of Mimyx cream in reducing the risk of relapse in Atopic Dermatitis. J Am Acad Dermatol, 2006; 54(3):AB80.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2011.11.009","article-title":"Endocannabinoids limit excessive mast cell maturation and activation in human skin","volume":"129","author":"Sugawara K","year":"2012","unstructured":"Sugawara K, , Biro T, , Tsuruta D, et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol, 2012; 129(3):726\u2013738.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"e_1_3_1_58_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bjd.14521","article-title":"N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis","volume":"175","author":"Kendall AC","year":"2016","unstructured":"Kendall AC, , Pilkington SM, , Sassano G, et al. N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis. Br J Dermatol, 2016; 175(1):163\u2013171.","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.1.22"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1746-6148-10-21","article-title":"Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis","volume":"10","author":"Abramo F","year":"2014","unstructured":"Abramo F, , Campora L, , Albanese F, et al. Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis. BMC Vet Res, 2014; 10:21.","journal-title":"BMC Vet Res"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000257","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:02Z","timestamp":1777399442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2,1]]}},"alternative-id":["10.1097\/DER.0000000000000257"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000257","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}